Skip to content

Discontinued — last reported Q3 '24

Business Segments · Amortization

Health & Science Technologies — Amortization

IDEX Health & Science Technologies — Amortization increased by 18.0% to $19.7M in Q3 2024 compared to the prior quarter.

Analysis

StatementSegment
CategoryProfitability
SignalContext dependent
VolatilityStable
First reportedQ3 2023
Last reportedQ3 2024Oct 30, 2024

How to read this metric

Higher amortization reflects a larger base of acquired intangible assets, often signaling recent M&A activity and potential future cash flow generation.

Detailed definition

The systematic allocation of the cost of intangible assets, such as patents, customer relationships, and trademarks, ove...

Peer comparison

Standard across industrial and life science sectors; peers with high M&A growth typically show higher amortization levels.

Metric ID: iex_segment_health_science_technologies_amortization

Historical Data

2 periods
 Q3 '23Q3 '24
Value$16.7M$19.7M
QoQ Change+18.0%
YoY Change+18.0%
Range$16.7M$19.7M
Avg YoY Growth+18.0%
Median YoY Growth+18.0%

Frequently Asked Questions

What is IDEX's health & science technologies — amortization?
IDEX (IEX) reported health & science technologies — amortization of $19.7M in Q3 2024.
What does health & science technologies — amortization mean?
The periodic expense recorded to account for the gradual loss of value of intangible assets over time.